Jump to Navigation

PREDICT BETTER

WITH TUMOR MUTATIONAL BURDEN

Today there’s more opportunity for doctors to
counsel better, forecast better, plan better.

Accuracy. It's in our DNA.

Introducing FoundationACT, our best-in-class,
reliable blood-based circulating tumor DNA assay

Learn More

FoundationOne Heme publishes
analytic validation and clinical

experience in Blood


Did you know

that more than 30% NSCLC patients with ALK fusions may have tested negatively for ALK by FISH*?

Learn more about the importance of comprehensive genomic profiling in lung cancer.

Every Cancer is Unique

Learn more about how FoundationOne can
help tailor your treatment options.

What is FoundationOne?

FoundationOne is a fully informative genomic profile that helps physicians make treatment decisions for patients with cancer by identifying the molecular growth drivers of their cancers and helping oncologists match them with relevant targeted therapeutic options.

Watch Now
 
Cancer and Treatment Options

Discover more about cancer and learn about available treatment options.

Watch Now
 
Featured Publications

View a list of our published and presented studies.

Read Now
 
 
Order a Test

Order Now

If you are a physician, there are a few ways to get started using FoundationOne (for solid tumors) or FoundationOne Heme (for hematologic malignancies, sarcomas and pediatric cancers) in your clinical practice.

If you are a patient, contact us for more information so you can talk with your doctor to see if FoundationOne or FoundationOne Heme is right for you.